GL1X · GenesisL1 explorer

MolNFT v1 · #136304 · protein

Structure-based design of ASK1 inhibitors as potential first-in-class agents for heart failure

5UOR: “Structure-based design of ASK1 inhibitors as potential first-in-class agents for heart failure”. X-ray diffraction, 2 ligands (8GV, SO4). MolNFT v1 #136304 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5UOR
Type
protein
Length
511 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q99683
Ligands
8GV, SO4

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein249—Q99683
B—protein262—Q99683

Ligands and binding sites

  • 8GV · 6-{[(2S)-4-methylmorpholin-2-yl]methoxy}-2-{6-[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]pyridin-2-yl}-2,3-dihydro-1H-isoindol-1-one · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5UOR · Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q99683 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase kinase kinase 5… · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.